Literature DB >> 20136501

FOXO4 induces human plasminogen activator inhibitor-1 gene expression via an indirect mechanism by modulating HIF-1alpha and CREB levels.

Elitsa Y Dimova1, Anatoly Samoylenko, Thomas Kietzmann.   

Abstract

The plasminogen activator inhibitor-1 (PAI-1) expression can be enhanced by hypoxia and various stimuli associated with oxidative stress. Among the FOXO transcription factors, FOXO4 appears to be crucial in the response against oxidative stress. Therefore, it was the aim of this study to investigate the role of peroxide-induced oxidative stress and FOXO4 on PAI-1 expression under normoxia and hypoxia. Treatment of cells with hydrogen peroxide increased PAI-1 mRNA, protein, and promoter activity, and knocking down FOXO4 abolished the peroxide-dependent PAI-1 induction. PAI-1 promoter reporter gene assays revealed that the peroxide and FOXO4-dependent induction was mediated through the HIF-1 and CREB-binding HRE within the PAI-1 promoter. Western blot analyses then indicated that peroxide and FOXO4 downregulated HIF-1alpha levels, whereas CREB levels were increased. Chromatin immunoprecipitations showed that FOXO4 did not bind the PAI-1 promoter, whereas CREB binding was enhanced on FOXO4 overexpression. In addition, knockdown of CREB abolished the FOXO4-mediated PAI-1 induction. Together, these findings provide the first evidence that oxidative stress and FOXO4 induce PAI-1 expression through an indirect mechanism involving modulation of HIF-1alpha and CREB protein levels and that enhanced CREB binding to the PAI-1 promoter is critical for the PAI-1 induction under oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20136501     DOI: 10.1089/ars.2009.2999

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  7 in total

1.  IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells.

Authors:  Simone Magagnin Wajner; Iuri Martin Goemann; Ana Laura Bueno; P Reed Larsen; Ana Luiza Maia
Journal:  J Clin Invest       Date:  2011-04-11       Impact factor: 14.808

2.  HIF-1 modulates longevity and healthspan in a temperature-dependent manner.

Authors:  Scott F Leiser; Anisoara Begun; Matt Kaeberlein
Journal:  Aging Cell       Date:  2011-02-23       Impact factor: 9.304

3.  MnTE-2-PyP reduces prostate cancer growth and metastasis by suppressing p300 activity and p300/HIF-1/CREB binding to the promoter region of the PAI-1 gene.

Authors:  Qiang Tong; Michael R Weaver; Elizabeth A Kosmacek; Brian P O'Connor; Laura Harmacek; Sujatha Venkataraman; Rebecca E Oberley-Deegan
Journal:  Free Radic Biol Med       Date:  2016-03-02       Impact factor: 7.376

4.  The prometastatic ribosomal S6 kinase 2-cAMP response element-binding protein (RSK2-CREB) signaling pathway up-regulates the actin-binding protein fascin-1 to promote tumor metastasis.

Authors:  Dan Li; Lingtao Jin; Gina N Alesi; Young-Mee Kim; Jun Fan; Jae Ho Seo; Dongsheng Wang; Meghan Tucker; Ting-Lei Gu; Benjamin H Lee; Jack Taunton; Kelly R Magliocca; Zhuo G Chen; Dong M Shin; Fadlo R Khuri; Sumin Kang
Journal:  J Biol Chem       Date:  2013-10-01       Impact factor: 5.157

5.  The PAX3-FOXO1 fusion protein present in rhabdomyosarcoma interferes with normal FOXO activity and the TGF-β pathway.

Authors:  Michel Schmitt-Ney; Giovanni Camussi
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

6.  Sodium selenite supplementation does not fully restore oxidative stress-induced deiodinase dysfunction: Implications for the nonthyroidal illness syndrome.

Authors:  Simone Magagnin Wajner; Helena Cecin Rohenkohl; Tulio Serrano; Ana Luiza Maia
Journal:  Redox Biol       Date:  2015-09-09       Impact factor: 11.799

7.  The relationship between deiodinase activity and inflammatory responses under the stimulation of uremic toxins.

Authors:  Gaosi Xu; Weiping Tu; Shulan Qin
Journal:  J Transl Med       Date:  2014-08-31       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.